Beam Therapeutics stockBEAM
Beam Therapeutics trades at $25.87, 32.4% below its 52-week high (Jul 7, 2026). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. −6.7% year to date, +12.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for BEAM — after you log in
Open the terminalFrequently asked questions about Beam Therapeutics
What is the Beam Therapeutics stock price?
At the close on Nov 5, 2026: $25.87 (−6.91% on the day). 52-week high: $38.26 on Jul 7, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Beam Therapeutics report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed −16% year over year, revenue −97%.
Does Beam Therapeutics pay dividends?
No, Beam Therapeutics does not pay dividends.
Where does Beam Therapeutics trade and how to buy it?
Ticker BEAM, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Beam Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BEAM are in the terminal after you log in.